Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Apolipoprotein E (ApoE) genotype and melatonin are linked to Alzheimer's disease (AD).
• The precise relationship between ApoE genotype and melatonin synthesis is not fully understood.
• Previous research indicated that astrocytes and glioma C6 cells can synthesize melatonin.

Purpose of the Study:

• To investigate the impact of different apolipoprotein E (ApoE) genotypes on melatonin biosynthesis.
• To elucidate the molecular mechanisms underlying ApoE's influence on melatonin production.

Main Methods:

• Establishment of C6 glioma cells with stable expression of ApoE isoforms (ApoE2, ApoE3, and ApoE4).
• Quantification of melatonin levels in cultured cells.
• Analysis of N-acetyltransferase (NAT) protein levels.
• Measurement of mRNA expression for monoamine oxidase A (MAOA) and monoamine oxidase B (MAOB).

Main Results:

• Cultured ApoE4-C6 cells exhibited significantly higher melatonin levels compared to ApoE3-C6 cells.
• N-acetyltransferase (NAT) protein levels were elevated in ApoE4-C6 cells.
• mRNA expression of monoamine oxidase A (MAOA) and monoamine oxidase B (MAOB) was reduced in ApoE4-C6 cells.

Conclusions:

• The increased melatonin biosynthesis in ApoE4-expressing cells is attributed to the upregulation of NAT, a critical enzyme in melatonin synthesis.
• Downregulation of MAOA and MAOB, enzymes involved in serotonin metabolism (melatonin precursor), also contributes to elevated melatonin levels.
• These findings suggest a direct link between ApoE genotype and melatonin production, with implications for Alzheimer's disease research.